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We report the identification of a novel polyomavirus present in respiratory secretions from human patients with
symptoms of acute respiratory tract infection. The virus was initially detected in a nasopharyngeal aspirate from a 3-
year-old child from Australia diagnosed with pneumonia. A random library was generated from nucleic acids extracted
from the nasopharyngeal aspirate and analyzed by high throughput DNA sequencing. Multiple DNA fragments were
cloned that possessed limited homology to known polyomaviruses. We subsequently sequenced the entire virus
genome of 5,229 bp, henceforth referred to as WU virus, and found it to have genomic features characteristic of the
family Polyomaviridae. The genome was predicted to encode small T antigen, large T antigen, and three capsid
proteins: VP1, VP2, and VP3. Phylogenetic analysis clearly revealed that the WU virus was divergent from all known
polyomaviruses. Screening of 2,135 patients with acute respiratory tract infections in Brisbane, Queensland, Australia,
and St. Louis, Missouri, United States, using WU virus–specific PCR primers resulted in the detection of 43 additional
specimens that contained WU virus. The presence of multiple instances of the virus in two continents suggests that this
virus is geographically widespread in the human population and raises the possibility that the WU virus may be a
human pathogen.
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Introduction
Viral infections of the respiratory tract are responsible for
signiﬁcant mortality and morbidity worldwide [1]. Despite
extensive studies in the past decades that have identiﬁed a
number of etiologic agents, including rhinoviruses, corona-
viruses, inﬂuenzaviruses, parainﬂuenzaviruses, respiratory
syncytial virus, and adenoviruses, approximately 30% of all
cases cannot be attributed to these agents, suggesting that
additional respiratory pathogens are likely to exist [2]. In fact,
since 2001, six previously undescribed viruses have been
identiﬁed by analysis of clinical specimens from the human
respiratory tract: human metapneumovirus [3], SARS coro-
navirus [4], coronavirus NL63 [5], coronavirus HKU1 [6],
human bocavirus [7], and the recently described KI virus [8].
In some instances, new molecular methods such as VIDISCA
[5], pan-viral DNA microarrays [9], and high throughput
sequencing [7,8] have played key roles in the identiﬁcation of
these agents. The advent of these new technologies has greatly
stimulated efforts to identify novel viruses in the respiratory
tract and in other human disease states.
Viruses in the family Polyomaviridae possess double-
stranded DNA genomes and infect a variety of avian, rodent,
and primate species. To date, two polyomaviruses, BK virus
and JC virus, have been unambiguously described as human
pathogens. BK and JC viruses are ubiquitous worldwide, and
in adult populations, seroprevalence rates approaching 75%
and 100%, respectively, have been reported [10]. Although
human polyomaviruses have been suggested to utilize a
respiratory route of transmission, detection of BK and JC
polyomavirus nucleic acids in the respiratory tract has rarely
been reported [11,12]. Infection with these two viruses is
predominantly asymptomatic, although in the context of
immunosuppression a number of syndromes have been
clearly linked to these viruses. JC virus causes primary
multifocal leukoencephalopathy, while BK virus has been
associated with a variety of renal and urinary tract disorders,
most importantly tubular nephritis, which can lead to
allograft failure in renal transplant recipients and hemor-
rhagic cystitis in hematopoietic stem cell transplant recipi-
ents [13]. These viruses are believed to persist in a latent
phase primarily in the kidney and can periodically undergo
reactivation. Excretion of BK and JC viruses in urine has been
reported in up to 20% of the general population [14,15].
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novel polyomavirus, KI, detected in human respiratory
secretions and stool [8]. However, the pathogenicity and
prevalence of this virus has not yet been established. In
addition, in the late 1950s, ;100 million people in the United
States, and many more worldwide, may have been exposed to
SV40, a polyomavirus that naturally infects rhesus monkeys
via contaminated polio vaccines, leading to widespread
debate about whether or not SV40 is capable of sustained
infection and replication cycles in humans [16].
Much of the interest in polyomaviruses and SV40 in
particular derives from the transforming properties carried
by the early transcriptional region of the viral genome that
encodes for the small T antigen (STAg) and and large T
antigen (LTAg). T antigen is capable of binding both p53 and
Rb proteins and interfering with their tumor suppressor
functions. The early region alone is sufﬁcient to transform
established primary rodent cell lines [17] and in concert with
telomerase and ras transforms primary human cells [18]. This
has lead to controversy over whether any human tumors are
associated with SV40 infection [19].
We describe the identiﬁcation and characterization of a
novel polyomavirus initially detected by high throughput
sequencing of respiratory secretions from a patient suffering
acute respiratory disease of unknown etiology. The virus was
detected in the respiratory secretions from an additional 43
patients in two continents, and the complete genomes of
multiple isolates were sequenced.
Results
Shotgun Sequencing of Respiratory Secretion
A nasopharyngeal aspirate (NPA) from a 3-year-old patient
admitted to the pediatric ward of the Royal Children’s
Hospital in Brisbane with pneumonia was collected in
October 2003. The patient had no other remarkable clinical
traits other than the respiratory features of pneumonia.
Testing of nucleic acid extracted from the NPA using a panel
of 17 PCR assays for known respiratory viruses as described
[20] yielded negative results. Total nucleic acid from the NPA
was randomly ampliﬁed and cloned as described previously
[9]. One 384-well plate of clones was sequenced using a
universal M13 primer, and the resulting sequence reads were
analyzed as described in Materials and Methods. Of the 384
reads, there were 37 poor quality sequences that were
rejected from further analysis, 327 human sequences, six
bacterial sequences, six viral sequences, and eight sequences
of unknown origin that could not be classiﬁed. The bacterial
sequences had greater than 97% nucleotide identity to
known bacterial species, including Haemophilus inﬂuenzae
(three reads), Streptococcus pneumoniae, Corynebacterium pseudo-
diphthericum, and Leifsonia xyli (unpublished data). Upon
further examination, the six viral reads were collapsed into
three unique regions, each of which possessed only limited
homology to known polyomavirus proteins (sequences
available in Figure S1). The highest scoring BLASTx hits for
each of these three contigs possessed 35%, 50%, and 34%
amino acid identity to JC virus STAg, BK virus LTAg, and
SV40 VP1, respectively. At the time these experiments were
performed, the KI virus genome had not yet been published.
Subsequent analysis revealed amino acid identities of 66%,
65%, and 69% to KI virus for the three contigs. Furthermore,
three of the eight previously unclassiﬁed sequence reads were
determined to have between 58%–84% amino acid identity
to KI virus VP1 and VP2 proteins by BLASTx analysis. Based
on the limited sequence homology to known viruses, we
tentatively assigned the name WU to the unknown poly-
omavirus.
Complete Genome Sequencing and Genome Analysis
The complete genome of WU was sequenced to 33
coverage using cloned fragments of the viral genome
generated by a series of PCR primers. Analysis of the DNA
sequence revealed genomic features characteristic of poly-
omaviruses. First, the WU genome size of 5,229 base pairs (bp)
was quite comparable to those of the primate polyomaviruses
BK (5,153 bp), JC (5,130 bp), and SV40 (5,243 bp). In addition,
the overall GC content of the WU genome was 39%, which is
quite similar to the GC content of BK (39%), JC (40%), and
SV40 (40%). The genome organization included an early
region coding on one strand for STAg and LTAg, and a late
region coding on the opposite strand for the capsid proteins
VP1, VP2, and VP3 (Figure 1). These two regions were
separated by a regulatory region that contained typical
polyomavirus features. The regulatory region contained an
AT-rich region on the late side of the putative replication
origin. Three repeats of the consensus pentanucleotide LTAg
binding site GAGGC were present, as was one copy of the
non-consensus LTAg binding site TAGGC. While most
polyomaviruses contain four copies of the consensus, baboon
polyomavirus (simian agent 12) is a primate polyomavirus
that contains only three copies of the canonical binding
sequence and one non-consensus binding site [21]. Unusual
features in the WU regulatory region included the presence
of two partially overlapping LTAg binding sites and slightly
variant spacing between the LTAg binding sites as compared
to SV40, BK, and JC (Figure S2).
In the early region, an unspliced open reading frame of 194
amino acids was detected that possibly encodes for the STAg.
As the paradigm in other polyomaviruses is that STAg is
expressed from a spliced message, analysis of potential splice
sites revealed the presence of a putative splice donor
sequence just one nucleotide 59 of the initially predicted
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Author Summary
We have identified a novel virus, referred to as WU virus, in the
family Polyomaviridae by screening of human respiratory secretions.
Two human polyomaviruses, BK and JC, were identified in 1971 and
infect the majority of humans around the world. These two viruses
are closely related to each other and are both are pathogenic in
immunocompromised individuals. Earlier this year, a third poly-
omavirus, KI, was described in human clinical specimens, although
its pathogenicity and prevalence in humans has not yet been
established. The discovery of WU virus brings the number of
polyomaviruses detected in humans to four. WU differs from BK and
JC significantly in its genome sequence and in its relative tissue
tropism, suggesting that it is likely to have unique biological
properties. This discovery raises many questions for further
investigation, such as, Is WU virus a human pathogen? If so, what
kind of disease does it cause? Where in the body does WU virus
reside? At what age does infection typically occur? Perhaps most
importantly, there are likely to be many more as of yet unidentified
viruses infecting the human body.stop codon. Splicing to a downstream putative splice accept-
or site would excise an intron of 70 nucleotides and generate
a slightly larger STAg of 217 amino acids (Figure S3). While
the precise carboxyl terminus of the WU STAg has not yet
been experimentally veriﬁed, sequence analysis revealed the
presence of a highly conserved cysteine-rich motif, CX5CX7–
8CXCX2CX21–22CSCX2CX3WF, that was present in both of the
predicted isoforms of WU STAg. This motif, which is present
in all STAgs, was perfectly conserved in WU virus with the
exception of the initial cysteine residue.
In all polyomaviruses, the initial ;80 amino acids of the N-
terminus of the STAg and LTAg are identical; the LTAg is
generated by alternative splicing of the early mRNA tran-
script. In WU virus, a conserved splice donor site was
identiﬁed immediately after amino acid 84 of the early open
reading frame. The position of the splice site is similar to that
found in SV40, BK, and JC virus, which occur after amino
acids 82, 81, and 81, respectively. Splicing to a conserved
splice acceptor site would generate a predicted protein of 648
amino acids (Table 1). The predicted WU virus LTAg
contained conserved features common to T antigens, includ-
ing a DnaJ domain in the N terminus with the highly
conserved hexapeptide motif HPDKGG; the LxCxE motif
necessary for binding Rb; a canonical DNA binding domain; a
zinc ﬁnger region; and conserved motifs GPXXXGKT and
GXXXVNLE in the ATPase-p53 binding domain [22].
Based on comparative sequence analysis of LTAgs, the
polyomaviruses are classiﬁed into two subclasses: a primate-
like group exempliﬁed by SV40, and a mouse polyoma-like
group exempliﬁed by murine polyoma virus [22]. Using these
criteria, the T antigen of WU appeared to more closely
resemble the mouse polyoma-like class of virus than the
primate class. First, the mouse polyoma-like viruses have
insertions of varying length after amino acids 66 and 113 of
SV40 as compared to the primate class. In the amino terminal
domain of the WU virus LTAg, multiple sequence alignment
revealed the presence of a two–amino acid and a ten–amino
acid insertion at these two loci, respectively. Furthermore, the
primate-like class typically contains an extension of the
carboxyl terminus termed the host range domain that is
absent in the mouse polyoma-like class. In contrast to SV40,
BK, JC, and baboon polyomavirus, WU virus did not appear
to encode a carboxyl terminal extension (Figure S4).
In addition to encoding LTAg and STAg, murine and
hamster polyomaviruses utilize alternative splicing to gen-
erate an intermediate-sized protein referred to as middle T
antigen. The WU virus early region was scanned for splicing
motifs similar to known murine and hamster polyomavirus
splice donor and acceptor sequences, but no obvious
combination of splice sites was detected that would yield a
middle T antigen sequence in the size range of known middle
T antigens. In addition, SV40, JC, BK, and baboon poly-
omavirus all encode a fourth late protein termed the
agnoprotein. There was no open reading frame present in
WU with any detectable homology to the known agnopro-
teins. Thus, our sequence analysis suggests that neither
middle T antigen nor agnoprotein are encoded by WU virus,
although it is possible that the sequences have diverged
beyond our ability to recognize the appropriate splice sites or
protein products.
Phylogenetic Analysis
Multiple sequence alignments of the predicted STAg,
LTAg, VP1, and VP2 open reading frames revealed that WU
Figure 1. Schematic of WU Virus Genome Organization
ori, origin of replication.
doi:10.1371/journal.ppat.0030064.g001
Table 1. Homology of Predicted WU Proteins
Gene Predicted Size (aa) % Amino Acid Identity
a to:
KI JC BK SV40 MuPy
c
STAg 194
b 68 40 41 38 23
LTAg 648 70 48 49 49 32
VP1 369 65 27 28 28 25
VP2 415 71 16 17 17 12
VP3 272 64 15 15 16 11
aCalculated using BioEdit.
bThe unspliced form was used to calculate % identity.
cMuPy, murine polyomavirus.
doi:10.1371/journal.ppat.0030064.t001
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virus (Figure 2). Neighbor-joining analysis suggested that
these two viruses appear to form a new subclass of
polyomaviruses. In the early region and VP1 protein, the
WU/KI branch was most closely related to the known primate
polyomaviruses BK, SV40, JC, and baboon polyomavirus
(Figure 2A–2C). Finally, the VP2 open reading frame was so
divergent that its evolutionary relationship to other poly-
omaviruses aside from KI could not be reliably established
(Figure 2D). Analysis of the VP3 amino acid sequence, which
is completely contained within VP2, gave similar results as
VP2 (unpublished data).
Prevalence of WU
PCR primers were designed to speciﬁcally amplify WU. The
initial screen used primers targeting the VP2 region, which
possessed less than 20% amino acid homology to JC and BK
virus to minimize the possibility of cross reactivity with the
known human polyomaviruses. Empirical testing of the
primers on samples known to contain BK and JC conﬁrmed
that the primers did not cross react with either of these
genomes (unpublished data). Positives in the initial screen for
WU virus were sequenced and then further conﬁrmed by a
second PCR reaction using primers targeting the 39 end of the
WU virus LTAg coding sequence. All 43 positive samples in
the initial screen were conﬁrmed using the second pair of
PCR primers. A subset of samples that tested negative in the
initial screen was also tested with the second PCR primer
pair, and none of those samples were positive.
Brisbane, Queensland, Australia, Cohort
In order to assess the prevalence of WU polyomavirus, a
cohort of 1,245 respiratory specimens collected in 2003 in
Brisbane was examined. Thirty-seven out of the 1,245 (3.0%)
samples tested were positive for the virus (Table 2). In this
cohort, patients that tested positive ranged in age from 4
months to 53 years. The vast majority of the patients (33/37)
were age 3 and under. In 12 patients with clear clinical
evidence of respiratory tract infection, WU was the sole virus
detected. Strikingly, in 25 of the 37 positive samples, one or
Figure 2. Phylogenetic Analysis of WU Virus
Amino acid–based phylogenetic trees were generated using the neighbor-joining method with 1,000 bootstrap replicates. Significant bootstrap values
are shown. A) STAg; B) LTAg; C) VP1; D) VP2.
doi:10.1371/journal.ppat.0030064.g002
PLoS Pathogens | www.plospathogens.org May 2007 | Volume 3 | Issue 5 | e64 0598
New Polyomavirus from Respiratory Tractmore additional respiratory viruses were also detected. The
most common co-infections were with rhinovirus (15 cases)
and human bocavirus (ten cases). Furthermore, in one
sample, a total of four viruses (WU, bocavirus, rhinovirus,
and adenovirus) were detected, and in six other samples, a
total of three viruses were detected (Table 2).
St. Louis, Missouri, United States, Cohorts
In addition, we examined two cohorts of patients from St.
Louis, Missouri, United States. In one set of upper respiratory
specimens collected in 2006, ﬁve out of 410 were positive for
WU virus in the PCR assay. In addition, 480 bronchoalveolar
lavage samples from patients (mostly adults) with severe acute
respiratory illness were tested, yielding one positive. Of the
positive samples, all six were co-infected with other viruses
(Table 2). The age range of the positive cases varied from 4
months to 51 years.
Strain Variants
To assess the sequence variation within different isolates,
we analyzed the 250-bp region encompassed by the initial
screening primers for all 43 cases (Figure 3). Several divergent
strains were detected, including one sample that had ﬁve
mutations (2%) within this region. In another case, a 12-bp
deletion was observed. The fact that many isolates were
identical in sequence was not surprising, given the relatively
short length of the amplicon and the double-stranded DNA
nature of the genome. In addition, we sequenced the
complete genome of ﬁve additional isolates from ﬁve
independent patients. Unfortunately, efforts to completely
Table 2. Patients Positive for WU Virus
ID Age (Years) Sex Sample Type Clinical Findings Viral Co-Infection
WU
a 3 M NPA Pneumonia
S1 51 M BAL Unexplained respiratory failure, ventilated Herpes simplex
S2 3 M NPS Neuroblastoma Metapneumo
S3 0.3 M NPS URTI Rhino
S4 2 M NPS Febrile respiratory infection with patchy pulmonary infiltrates Influenza B
S5 0.4 F NPS URTI Adeno
S6 19 F NPS Influenza-like illness, reactive airways disease, pregnant Influenza B
B1 53 M BAL LRTI, Wegner granulomatosis
B2 0.9 M NPA Bronchiolitis
B3 43 M BW HIV, Kaposi sarcoma Epstein–Barr
B4 2 M NPA LRTI, cystic fibrosis
B5 2 M NPA LRTI, post bone marrow transplant Respiratory syncytial virus
B6 1 F NPA Gastroenteritis Rhino
B7 0.9 M NPA Bronchiolitis Rhino
B8 0.8 M NPA Bronchiolitis Metapneumo, rhino
B9 6 M NPA LRTI, febrile neutropaenia, ALL Metapneumo
B10 1 M NPA URTI, gastroenteritis
B11 2 M NPA Pneumonia
B12 2 F NPA URTI Bocavirus, entero
B13 2 M NPA LRTI, cerebral palsy
B14 1 M NPA URTI
B15 2 F NPA URTI Influenza A
B16 2 F NPA Bronchiolitis Rhino
B17 0.6 M NPA Bronchiolitis Rhino
B18 2 M NPA LRTI Bocavirus
B19 0.6 M NPA URTI, gastroenteritis Rhino
B20 1 M NPA URTI Bocavirus
B21 0.6 M NPA Bronchiolitis
B22 0.3 M NPA URTI Rhino
B23 0.6 M NPA URTI Rhino
B24 1 F NPA URTI, febrile convulsion Adeno, rhino, bocavirus
B25 0.8 M NPA Bronchiolitis
B26 3 F NPA URTI
B27 6 F NPA URTI, post bone marrow transplant
B28 2 M NPA Infective exacerbation of bronchiectasis Entero
B29 1 F NPA LRTI
B30 0.3 M NPA URTI Rhino, bocavirus
B31 0.6 M NPA Bronchiolitis Rhino
B32 3 F NPA URTI Bocavirus
B33 1 M NPA URTI Rhino, bocavirus
B34 0.8 M NPA Bronchiolitis Bocavirus, parainfluenza 3
B35 2 F NPA LRTI Rhino, bocavirus
B36 0.9 M NPA LRTI, ETT, ventilated Bocavirus
B37 2 M NPA Croup Rhino
aOriginal case.
ALL, acute lymphoblastic leukemia; BAL, bronchoalveolar lavage; BW, bronchial washings; ETT, endotracheal tube in place; LRTI, lower respiratory tract infection; NPS, nasopharyngeal
swab; URTI, upper respiratory tract infection.
doi:10.1371/journal.ppat.0030064.t002
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bp sequence, B2 and B3) have been unsuccessful, presumably
due to low viral titers in these samples. All six complete
genomes were 5,229 bp in size, and overall, there was between
0.08% and 0.23% sequence variation from sample to sample,
well above that expected from Taq PCR, ruling out the
possibility that the additional positives were artifacts of PCR
contamination. Moreover, the majority of the observed
mutations were synonymous substitutions or in non-coding
regions, lending further support to the argument that these
were authentic strain variants. For JC virus, the reported
intratype sequence variation is of a similar magnitude,
ranging between 0.1% and 0.5% [23].
Screening of Urine
Because BK and JC virus are frequently excreted in urine,
we examined urine samples from patient cohorts in both St.
Louis and Brisbane for the presence of WU virus by PCR. In
the St. Louis cohort, urine samples from 200 adult patients
participating in a study of polyomavirus infections in kidney
transplant recipients were tested [24]. For most patients,
samples were tested at three time points: prior to transplant,
1 mo post transplant, and 4 mo post transplant, although for
some patients the pre-transplant specimen was not available.
Zero out of 501 samples tested were positive for the WU
polyomavirus. As a control, using previously validated BK
primers, we were able to amplify BK virus in a subset of these
urine samples, conﬁrming the integrity of the specimens
themselves (unpublished data). Similarly, from the Brisbane
cohort, none of the 226 urine samples tested were positive for
WU virus.
Discussion
We used a high throughput sequencing strategy to search
for novel agents that were present in respiratory tract
infections of unknown etiology. The focus of this study was
on individual clinical specimens that still lacked a diagnosis
after analysis with an extensive panel of diagnostic assays for
known respiratory viruses. In one such patient sample, novel
sequences with limited homology to known polyomaviruses
were detected. Complete genome sequencing and phyloge-
netic analysis revealed that the new virus clearly had the
genomic organization typical of polyomaviruses but was
divergent from all previously described polyomaviruses. In
keeping with the two-letter virus names for human poly-
omaviruses, we have named this novel polyomavirus WU virus
[25,26]. Overall, the predicted amino acid sequences of WU
virus proteins were most similar to the newly described KI
virus (Table 1). Outside of KI, WU shared only ;15%–49%
identity to its closest relatives (Table 1).
Detailed analysis of the viral DNA sequence and genomic
organization conﬁrmed the novelty of WU virus. At all loci,
WU virus was most similar to KI virus, but the degree of
divergence between WU and KI was greater than the
divergence between SV40 and BK, indicating that WU and
KI are clearly distinct viruses (Figure 2). Based on the
phylogenetic analysis, it appears that WU and KI deﬁne a
novel branch within the Polyomaviridae family (Figure 2).
Relative to the established polyomaviruses, some analyses
suggested that the WU/KI branch might be more closely
related to the primate polyomaviruses, while other features of
the WU genome suggested that it might be more similar to
murine polyomavirus. For example, neighbor-joining phylo-
genetic analysis suggested that the predicted STAg, LTAg,
and VP1 open reading frames of both KI and WU were most
closely related to SV40, JC, BK, and baboon polyomaviruses.
Analysis of the VP2/VP3 region was more equivocal, as the
proteins were too divergent to reliably assess. The apparent
absence of the C-terminal ‘‘host range’’ domain in the LTAg
and the agnoprotein open reading frame, both of which are
present in the known primate polyomaviruses, suggested that
WU virus was more similar to murine polyomavirus than the
primate polyomaviruses by these criteria. While the evolu-
tionary history of this virus is not clear at the moment, the
totality of the analysis indicates that WU is clearly a unique
virus.
We detected WU in 37 out of 1,245 (3.0%) patient
specimens in Brisbane (excluding the original case) and in
six out of 890 (0.7%) patient specimens tested in St. Louis. As
the positive specimens were all collected from 2003 through
2006, it appears that WU is currently circulating, and its
presence in both North America and Australia suggests that
the virus is geographically widespread in the human
population. The age range of patients that tested positive
for WU virus spanned from 4 months to 53 years. The
majority (86%) of the cases were found in children 3 years of
age and under. Of the four positive specimens from adult
patients (S1, S6, B1, and B3 in Table 2), three clearly had
altered immune status. One patient was HIV-positive, one was
immunosuppressed due to treatment for Wegener granulo-
Figure 3. Strain Variation of WU virus
A 250-bp fragment of the VP2 gene was aligned using ClustalX. WU
indicates the original case, and strain designations correspond to
patients as listed in Table 2.
doi:10.1371/journal.ppat.0030064.g003
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while not obviously immunosuppressed, also suffered from
liver cirrhosis, hypertension, type 2 diabetes, and co-infection
with herpes simplex virus, and required mechanical ventila-
tion. In addition, there were two other positive patients older
than 3 years of age: a 6-year-old child who had previously
been a bone marrow transplant recipient (Table 2, B27) and a
6-year-old child diagnosed with acute lymphoblastic leukemia
(Table 2, B9). While preliminary, the age distribution of the
positive cases in this study combined with the established
paradigms for BK and JC virus suggest a model where acute
infection with WU virus may occur relatively early in life and
result in a latent infection. Immunosuppression or other
insults such as viral infection could then lead to reactivation
of WU virus in older individuals.
The patients who yielded positive specimens suffered from
a wide range of respiratory syndromes, including bronchio-
litis, croup, and pneumonia as well as other clinical maladies
(Table 2). Detection of WU virus sequences in these patients is
merely the ﬁrst step in assessing the potential etiologic role of
WU virus in acute respiratory tract disease. It is not yet
known whether WU is infectious or whether it is capable of
replication in the respiratory tract. One possibility is that WU
is not involved at all in respiratory disease, but rather is
simply transmitted by the respiratory route. The human
polyomaviruses BK and JC are hypothesized to be transmitted
by the respiratory route before taking up residency primarily
in the kidneys. Latency in the kidneys of BK and JC is believed
to be the reason that both viruses are excreted in the urine of
up to 20% of asymptomatic individuals [14,15]. In this study,
using the same PCR assays that were effective in respiratory
secretions, we did not detect WU in any of the 727 urine
samples we tested. The lack of detection of WU virus in the
urine may reﬂect sensitivity issues, a bias in the cohorts
tested, or simply that WU is unlike BK and JC viruses and is
not secreted in the urine. A similar tissue proﬁle to that of
WU virus has been reported in initial studies of KI virus [8].
Future experiments will aim to determine the tissue tropism
of WU and whether any tissue reservoirs for WU virus exist.
In the literature, there is one animal polyomavirus that has
been found extensively in lung tissue. Infection of suckling
mice with the mouse pneumotropic polyomavirus (MPPV)
causes interstitial pneumonia and signiﬁcant mortality.
MPPV also differs from other polyomaviruses in that besides
the kidneys, it can also be detected in the lungs, liver, spleen,
and blood of suckling mice [27]. Thus, there is precedence for
an animal polyomavirus causing respiratory disease, suggest-
ing at least the possibility that WU virus could be similarly
pathogenic in humans.
One striking observation from these studies is the relatively
high frequency of co-infection detected in the respiratory
secretions: 72% overall (100% in the St. Louis cohort and
68% in the Brisbane cohort). Although more extensive
studies are necessary to conﬁrm the generality of this
observation, this raises several intriguing non-mutually
exclusive possibilities to consider: 1) WU may be an
opportunistic pathogen; 2) WU infection may predispose or
facilitate secondary infection by other respiratory viruses;
and 3) WU may be a part of the endogenous viral ﬂora that is
reactivated by inﬂammation or some other aspect of viral
infection. Recent studies of the prevalence of the newly
identiﬁed human bocavirus have also reported higher levels
of co-infection than previously described for other viruses
found in the respiratory tract, with co-infection rates as high
as 50% reported [28,29]. In addition, ﬁve of six samples
positive for KI virus were reported to be co-infected with
other known respiratory viruses [8]. As detection methods
improve in sensitivity and more comprehensive efforts are
made to examine the diversity of viruses found in the
respiratory tract, a greater appreciation for the rates of dual
or multi-infection is gradually emerging. For example, the use
of extensive panels of PCR assays in this study revealed that
one of the positive specimens was quadruply infected;
adenovirus, rhinovirus, and bocavirus and WU virus were
all present. Further investigations that aim to systematically
deﬁne the spectrum of viruses present in the respiratory tract
are clearly warranted so that the possible roles that co-
infections may play in disease pathogenesis can be explored.
Extremely high sequence divergence was observed in the
capsid proteins VP1 and VP2 of WU virus and KI virus as
compared to the other known polyomaviruses. This diver-
gence may reﬂect a different ‘‘lifestyle’’ for the WU/KI branch
as compared to known polyomaviruses. Our data demon-
strating the presence of WU in respiratory secretions and its
absence in urine samples suggest that the mode of trans-
mission or the sites of persistence of WU may be distinct from
the other human polyomaviruses. As such, the structure of
the virion must be optimized to enable the virus to survive
dramatically distinct physiological and environmental con-
ditions. This may partially explain the observed sequence
divergence in the capsid proteins.
Another question raised by this study relates to the
potential antigenic cross reactivity of the WU capsid proteins.
In terms of establishing the seroprevalence of WU itself and
determining whether seroconversion accompanies acute
infection with WU, it will be essential to conduct these
studies with consideration for potential cross reactivity to KI,
BK, JC, and SV40 antibodies. In addition, it is tantalizing to
speculate whether serum antibodies to WU have the potential
to cross react to SV40-derived antigens, and if so, whether
they may at least partially account for some of the studies that
report the presence of SV40 antibodies in the human
population that is too young to have suffered exposure from
contaminated polio vaccination [30–32].
In conclusion, we have identiﬁed and completely se-
quenced the genome of a novel polyomavirus. This virus
appears to be geographically widespread in the human
population as evidenced by the detection of 44 distinct cases
in two continents. Based on preliminary analysis, WU and KI
virus share some strikingly similar properties, including their
complement of genes, phylogenetic relationship, and physical
sites of detection in the human body. These data suggest that
WU virus and KI virus deﬁne a novel branch within the
Polyomaviridae family with unexplored biology and patho-
genicity. Another implication of these results is that the
diversity of viruses in this family may be far greater than
currently realized. Further experimentation is now underway
to determine the relative pathogenicity of WU virus in
humans and to understand the molecular properties of the
virus. Since the T antigen of WU is predicted to have
transforming properties by analogy to other polyomavirus T
antigens, one question currently under investigation is
whether a subset of human tumors may be associated with
WU.
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Clinical specimens—Respiratory secretions. Brisbane cohort. A
total of 1,245 specimens (predominantly NPAs) were collected
between January 1, 2003, and December 22, 2003, from patients
presenting to the Royal Children’s Hospital in Brisbane, Queensland,
Australia, with symptoms consistent with acute lower respiratory
tract infection.
St. Louis cohort #1. A total of 480 BAL specimens were tested.
These included samples from a retrospective and a prospective
collection. The retrospective specimens were from a sequential
collection of BAL specimens submitted routinely to the Virology
Laboratory at St. Louis Children’s Hospital between December 2002
and August 2003 [33]. For the present study, an effort was made to
select specimens from this collection from patients with acute
respiratory illness, and to exclude specimens collected as routine
post–lung transplant surveillance. The prospective specimens were
from an ongoing study of the etiology of severe acute respiratory
illness and were collected between October 2005 and October 2006.
Both collections included specimens from patients of all ages,
although the large majority were from adults.
St. Louis cohort #2. This collection was made up of respiratory
specimens, mostly nasopharyngeal swabs, submitted for routine
virologic testing to the Virology Laboratory at St. Louis Children’s
Hospital between September 2005 and June 2006. The majority of
these specimens were from children. Of the 410 specimens in this
collection, 200 were selected because they had been found to be
positive by ﬂuorescent antibody staining or culture for inﬂuenzavirus
A or B, respiratory syncytial virus, parainﬂuenza virus, rhinovirus, or
adenovirus.
Clinical specimens—Urine. Brisbane cohort. Urine specimens
(226) that were submitted during 2003 to the diagnostic laboratory
for routine investigation were collected. These represented a diverse
mixture of donors, including those from (i) sexual health clinic (n ¼
50), (ii) pediatric clinic (n ¼ 52), (iii) antenatal clinic (n ¼ 33), (iv)
indigenous health clinic (n ¼ 36), and (v) bone marrow transplant
patients (n ¼ 55).
The St. Louis urine specimens were from a study of polyomaviruses
in adult renal transplant recipients [24]. A total of 200 individuals
were enrolled in the study between December 2000 and October
2002. From each patient, up to three specimens were tested,
including a specimen obtained before the transplant and specimens
obtained at 1 and 4 mo after transplantation.
Diagnostic testing of clinical specimens for known respiratory
viruses. Brisbane cohort. Nucleic acids were extracted from 0.2 ml of
each specimen using the High Pure Viral Nucleic Acid kit (Roche
Diagnostics Australia, http://www.rochediagnostics.com.au) according
to the manufacturer’s instructions. PCR assays for 17 known
respiratory viruses were performed as described [20].
St. Louis cohort. All respiratory specimens were tested originally
by ﬂuorescent antibody staining using a panel of monclonal
antibodies directed against inﬂuenza A and B, respiratory syncytial,
parainﬂuenza 1–3, and adenoviruses (Simulﬂuor Respiratory Screen;
Chemicon, http://www.chemicon.com). Specimens that were negative
were also cultured using cell culture systems that could detect the
same group of viruses plus rhinoviruses, cytomegalovirus, and herpes
simplex virus. Total nucleic acid extracts were puriﬁed using a
Qiagen M48 instrument (http://www.qiagen.com). Nucleic acid ex-
tracts were tested for a panel of respiratory viruses using the EraGen
MultiCode-PLx respiratory virus panel (EraGen Biosciences, http://
www.eragen.com), a multiplex PCR assay that detects the following
viruses: inﬂuenza A and B, respiratory syncytial virus A and B,
parainﬂuenza 1–4, human meatpneumovirus, adenovirus subgroups
B, C, and E, rhinoviruses, and coronaviruses OC43, 229E, and NL63.
Library construction and shotgun sequencing. Samples were
prepared in the following manner for high throughput sequencing
analysis. A total of 200 ul of neat NPA sample was thawed and directly
treated with DNase I (Fermentas, http://www.fermentas.com) for 60
min at 37 8C. Total nucleic acid was extracted using the Masterpure
Complete DNA and RNA Puriﬁcation Kit (Epicentre Biotechnologies,
http://www.epibio.com). Then, 100 ng of total nucleic acid was
randomly ampliﬁed using the RdAB protocol exactly as described
[9]. RNA in the total nucleic acid preparation was converted to cDNA
by reverse transcription with primer-A (59 GTTTCCCAGTCACGA-
TANNNNNNNNN). Two rounds of random priming with primer-A
and extension with Sequenase (United States Biochemical, http://
www.usbweb.com) enabled second strand cDNA synthesis as well as
random priming of DNA originally present in the total nucleic acid
sample. Amplicons were then generated via 40 cycles of PCR using
primer-B (59 GTTTCCCAGTCACGATA) with a cycling proﬁle of: 94
8C3 0s ;4 08C3 0s ;5 08C3 0s ;7 28C 60 s. The primer-B–ampliﬁed
material was TOPO cloned into pCR4.0 (Invitrogen, http://www.
invitrogen.com) and transformed into bacteria, and white colonies
were picked into 384-well plates. DNA was puriﬁed by magnetic bead
isolation and sequenced using standard Big Dye terminator (v3.1)
sequencing chemistry. Reaction products were ethanol precipitated,
resuspended in 25 ul of water, and loaded onto the ABI 3730xl
sequencer.
Analysis of shotgun sequences. Sequences were assessed for quality
using Phred [34], and reads that contained less than 50 contiguous
bases with a score of phred 20 or greater were rejected. The
remaining reads were analyzed in the following steps: 1) reads were
aligned to the human genome using BLASTn with an e
 10 cutoff; 2)
remaining reads were aligned to a bacterial database using BLASTn
with an e
 10 cutoff; and 3) remaining reads were aligned to the viral
RefSeq protein database using BLASTx with an e
 2 cutoff [35].
Complete genome ampliﬁcation and sequencing. The WU genome
derived from the index case was sequenced to 33 coverage using six
unique pairs of PCR primers for the ampliﬁcation. Amplicons were
cloned into pCR4.0 and sequenced using standard sequencing
technology. All primers used for ampliﬁcation and sequencing are
listed in Table S1 and their positions depicted in Figure S5.
Additional complete genomes were sequenced to at least 23coverage
using the same primers listed in Table S1. Completed genome
sequences have been deposited into GenBank (see Supporting
Information for accession numbers).
Phylogenetic analysis. Protein sequences associated with the
following reference virus genomes were obtained from GenBank:
BK virus, JC virus, bovine polyomavirus, SV40, baboon polyomavirus
(simian agent 12), ﬁnch polyomavirus, crow polyomavirus, goose
hemorrhagic polyomavirus, African green monkey polyomavirus,
budgerigar ﬂedgling polyomavirus, murine pneumotropic virus,
hamster polyomavirus, and murine polyomavirus (see Supporting
Information for accession numbers). For WU virus, predicted open
reading frames were used. For STAg, the predicted open reading
frame of 194 amino acids was used for analysis. Multiple sequence
alignment was performed using ClustalX (1.83). Neighbor-joining
trees were generated using 1,000 bootstrap replicates.
Nucleic acid prevalence studies. For all PCR assays, standard
precautions to avoid end product contamination were taken,
including the use of PCR hoods and maintaining separate areas for
PCR set up and analysis. For initial screening of WU virus, PCR
primers AG0044 59 tgttacaaatagctgcaggtcaa and AG0045 59 gctgca-
taatggggagtacc were used with Accuprime hot start Taq (Invitrogen)
to amplify 1 ul of template using the following program: 40 cycles of
94 8C3 0s ;5 68C3 0s ;7 28C 60 s. For every 88 samples tested, seven no-
template negative controls were interspersed between the actual
samples. Products were visualized following electrophoresis on 1%
agarose gels. The resulting 250-bp amplicon was sequenced directly in
both directions using primer AG0044 and AG0045. These sequences
have been deposited in GenBank (see Supporting Information for
accession numbers). Secondary conﬁrmation was performed using
primers AG0048 59 TGTTTTTCAAGTATGTTGCATCC and AG0049
59 CACCCAAAAGACACTTAAAAGAAA that generate a 244-bp
amplicon in the 39 end of the LTAg coding region. The same cycling
proﬁle of 40 cycles of 94 8C3 0s ;5 68C3 0s ;7 28C 60 s was used. For
detection of both BK and JC viruses, primers AG0068 59 AGTCTT-
TAGGGTCTTCTACC and AG0069 59 GGTGCCAACCTATGGAA-
CAG were used with a proﬁle of 40 cycles of 94 8C3 0s ;5 68C3 0s ;7 2
8C6 0s .
Supporting Information
Figure S1. Raw Sequence Data from High Throughput Screening
A) The initial six shotgun reads with homology to polyomaviruses. B)
The three contigs derived from the six reads.
Found at doi:10.1371/journal.ppat.0030064.sg001 (38 KB PDF).
Figure S2. Comparison of SV40 and WU Virus Replication Origin
Region
The consensus TAg binding motif is GAGGC. The known primate
polyomaviruses SV40, JC, BK, and baboon polyomavirus all have four
copies of the copies of the binding site oriented as shown above for
SV40 (NC_001669). The ﬁrst nucleotide of the third copy of the
consensus TAg binding site is deﬁned as nucleotide 1 for WU and
SV40. Differences between SV40 and WU Virus are 1) one of the TAg
binding sites in WU virus appears to be a non-canonical TAGGC; 2)
the second and third consensus TAg binding sites in WU virus
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in WU virus varies from the prototype SV40 as shown. Shown in blue
is the polyA/T tract that is commonly found to the late side of the
origin in polyomaviruses
Found at doi:10.1371/journal.ppat.0030064.sg002 (462 KB PDF).
Figure S3. Predicted Splice Sites for LTAg and STAg
A consensus LTAg donor site was detected. Splicing to the consensus
downstream acceptor would generate a LTAg of 648 amino acids. For
STAg, an unspliced open reading frame of 194 amino acids was
identiﬁed. A predicted slice donor site was also detected that would
result in excision of a 70-nucleotide intron and production of a 217–
amino acid open reading frame.
Found at doi:10.1371/journal.ppat.0030064.sg003 (542 KB PDF).
Figure S4. WU Virus Lacks a Carboxyl Terminus Extension of the the
LTAg
Multiple sequence alignment of WU virus LTAg with 13 other
reference sequences reveal the presence of carboxyl terminus
extensions in baboon polyoma, BK, JC, and SV40. WU virus does
not appear to encode such a region.
Found at doi:10.1371/journal.ppat.0030064.sg004 (5.4 MB PDF).
Figure S5. Map of Primers and Sequence Reads
Locations of original shotgun reads are depicted as indicated.
Locations of all sequencing primers are mapped to the complete
genome. Primers used for ampliﬁcation are shown in red.
Found at doi:10.1371/journal.ppat.0030064.sg005 (551 KB PDF).
Table S1. Primers Used for Ampliﬁcation and Sequencing of WU
Virus
Found at doi:10.1371/journal.ppat.0030064.st001 (35 KB PDF).
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) protein sequen-
ces used in this paper are as follows:
LTAg: African green monkey (NP_848008); baboon polyomavirus
1 (YP_406555); BK (YP_717940); bovine (NP_040788); budgerigar
(NP_848014); crow (YP_529828); ﬁnch (YP_529834); goose
(NP_849170); hamster (NP_056730); JC (NP_043512); KI Stock-
holm 60 (ABN09921); murine (NP_041264); murine pneumotropic
(NP_041232); SV40 (NP_043127).
STAg: African green monkey (NP_848009); baboon polyomavirus
1 (YP_406556); BK (YP_717941); bovine (NP_040789); budgerigar
(NP_848015); crow (YP_529829); ﬁnch (YP_529835); goose
(NP_849171); hamster (NP_056732); JC (NP_043513); KI Stock-
holm 60 (ABN09920); murine (NP_041266); murine pneumotropic
(NP_041233); SV40 (NP_043128).
VP1: African green monkey (NP_848007); baboon polyomavirus 1
(YP_406554); BK (YP_717939); bovine (NP_040787); budgerigar
(NP_848013); crow (YP_529827); ﬁnch (YP_529833); goose
(NP_849169); hamster (NP_056733); JC (NP_043511); KI Stock-
holm 60 (ABN09917); murine (NP_041267); murine pneumotropic
(NP_041234); SV40 (NP_043126).
VP2: African green monkey (NP_848005); baboon polyomavirus 1
(YP_406552); BK (YP_717937); bovine (NP_040785); budgerigar
(NP_848011); crow (YP_529825); ﬁnch (YP_529831); goose
(NP_849167); hamster (NP_056734); JC (NP_043509); KI Stock-
holm 60 (ABN09918); murine (NP_041268); murine pneumotropic
(NP_041235); SV40 (NP_043124).
WU complete genome sequences have been deposited under
accession numbers EF444549–EF444554. VP2 partial sequences have
been deposited under accession numbers EF444555–EF444593.
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